BG100396A - Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им - Google Patents

Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им Download PDF

Info

Publication number
BG100396A
BG100396A BG100396A BG10039696A BG100396A BG 100396 A BG100396 A BG 100396A BG 100396 A BG100396 A BG 100396A BG 10039696 A BG10039696 A BG 10039696A BG 100396 A BG100396 A BG 100396A
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
straight
branched
chain
alkyl
Prior art date
Application number
BG100396A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gabriele Braeunlich
Ruediger Fischer
Mazen Es-Sayed
Rolf Henning
Michael Sperzel
Karl-Heinz Schlemmer
Ulrich Nielsch
Stephen Tudhope
Graham Sturton
Trevor Abram
Mary Fitzgerald
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG100396A publication Critical patent/BG100396A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
BG100396A 1995-03-06 1996-03-04 Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им BG100396A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
BG100396A true BG100396A (bg) 1996-12-31

Family

ID=10770709

Family Applications (2)

Application Number Title Priority Date Filing Date
BG100396A BG62732B1 (bg) 1995-03-06 1996-03-04 Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им
BG100396A BG100396A (bg) 1995-03-06 1996-03-04 Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG100396A BG62732B1 (bg) 1995-03-06 1996-03-04 Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им

Country Status (42)

Country Link
US (2) US6399657B1 (fr)
EP (1) EP0731099B1 (fr)
JP (1) JP3204901B2 (fr)
KR (2) KR100405579B1 (fr)
CN (2) CN1176651C (fr)
AR (1) AR002710A1 (fr)
AT (1) ATE193704T1 (fr)
BG (2) BG62732B1 (fr)
BR (1) BR9600930A (fr)
CA (1) CA2170824A1 (fr)
CO (1) CO4370145A1 (fr)
CZ (1) CZ66796A3 (fr)
DE (1) DE69608721T2 (fr)
DK (1) DK0731099T3 (fr)
DZ (1) DZ1998A1 (fr)
EE (1) EE03921B1 (fr)
ES (1) ES2147320T3 (fr)
FI (1) FI960998A (fr)
GB (1) GB9504460D0 (fr)
GR (1) GR3034240T3 (fr)
HK (1) HK1013285A1 (fr)
HR (1) HRP960071B1 (fr)
HU (1) HU222282B1 (fr)
IL (1) IL117349A (fr)
MA (1) MA23815A1 (fr)
MY (1) MY117526A (fr)
NO (1) NO313672B1 (fr)
NZ (1) NZ286107A (fr)
PE (1) PE43597A1 (fr)
PL (1) PL189206B1 (fr)
PT (1) PT731099E (fr)
RO (1) RO116622B1 (fr)
RU (1) RU2162845C2 (fr)
SI (1) SI0731099T1 (fr)
SK (1) SK281817B6 (fr)
SV (1) SV1996000015A (fr)
TN (1) TNSN96035A1 (fr)
TR (1) TR199600177A2 (fr)
TW (1) TW336934B (fr)
UA (1) UA46714C2 (fr)
YU (1) YU49359B (fr)
ZA (1) ZA961774B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) * 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
JP2002529444A (ja) * 1998-11-12 2002-09-10 アリアド・ファーマシューティカルズ・インコーポレイテッド 二環式シグナル伝達阻害剤、それを含む組成物とその用途
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350109A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
BR0307905A (pt) * 2002-02-22 2006-04-04 Bayer Pharmaceuticals Corp derivados de benzotiofeno e benzofurano úteis no tratamento de distúrbios hiperproliferativos
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
CA2506415A1 (fr) 2002-11-19 2004-06-03 Achillion Pharmaceuticals, Inc. Aryl thio-urees substituees et composes analogues, inhibiteurs de la replication virale
WO2004063181A1 (fr) * 2003-01-03 2004-07-29 Genzyme Corporation Derives d'uree et leur utilisation comme agents anti-inflammatoires
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (fr) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. Nouveau dérivé de furopyridine, composition pharmaceutique comprenant le dérivé et utilisation du dérivé ou de la composition
WO2008003701A2 (fr) 2006-07-05 2008-01-10 Nycomed Gmbh Combinaison d'inhibiteurs de hmg-coa réductase et d'inhibiteurs de phosphodiestérase 4 pour le traitement de maladies pulmonaires inflammatoires
US20140057978A1 (en) 2011-03-17 2014-02-27 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (fr) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Utilisation de benzofuranylsulfonates dans la douleur neuropathique
JP6488000B2 (ja) 2014-03-18 2019-03-20 アルジアックス ファーマシューティカルズ ゲーエムベーハー ２−シアノ−３−シクロプロピル−３−ヒドロキシ−ｎ−アリール−チオアクリルアミド誘導体
EP3165224A1 (fr) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Utilisation d'inhibiteurs de pde4 pour la prophylaxie et/ou la thérapie de la dyslipoproteinémie et des troubles apparentés
WO2017089347A1 (fr) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Procédés et compositions pharmaceutiques pour le traitement de mélanomes résistant aux inhibiteurs de braf
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (fr) 2020-12-22 2022-06-29 Paul Scherrer Institut Procédé de production d'optique à rapport de forme élevé en forme de ventilateur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA824343B (en) * 1981-07-01 1983-04-27 Upjohn Co Pyridinyl- and imidazolyl-benzofurane and benzothiophenes
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (fr) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Inhibiteurs de la lipoxygénase
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
YU49359B (sh) 2005-09-19
BR9600930A (pt) 1997-12-30
US6677372B2 (en) 2004-01-13
ATE193704T1 (de) 2000-06-15
CN1176651C (zh) 2004-11-24
NO960884D0 (no) 1996-03-05
GR3034240T3 (en) 2000-12-29
IL117349A (en) 2002-09-12
UA46714C2 (uk) 2002-06-17
FI960998A0 (fi) 1996-03-04
TR199600177A2 (tr) 1996-10-21
NZ286107A (en) 1998-08-26
FI960998A (fi) 1996-09-07
HU222282B1 (hu) 2003-05-28
AU4582896A (en) 1996-09-19
KR100405579B1 (ko) 2004-03-19
IL117349A0 (en) 1996-07-23
TNSN96035A1 (fr) 2005-03-15
US20030109578A1 (en) 2003-06-12
RO116622B1 (ro) 2001-04-30
EE03921B1 (et) 2002-12-16
CN1313284A (zh) 2001-09-19
CO4370145A1 (es) 1996-10-07
RU2162845C2 (ru) 2001-02-10
MA23815A1 (fr) 1996-10-01
KR960034194A (ko) 1996-10-22
CA2170824A1 (fr) 1996-09-07
HUP9600549A2 (en) 1997-07-28
NO313672B1 (no) 2002-11-11
AR002710A1 (es) 1998-04-29
HRP960071B1 (en) 2001-04-30
YU13396A (sh) 1999-06-15
HK1013285A1 (en) 1999-08-20
TW336934B (en) 1998-07-21
GB9504460D0 (en) 1995-04-26
SK281817B6 (sk) 2001-08-06
HU9600549D0 (en) 1996-04-29
NO960884L (no) 1996-09-09
PL189206B1 (pl) 2005-07-29
BG62732B1 (bg) 2000-06-30
PL313070A1 (en) 1996-09-16
US6399657B1 (en) 2002-06-04
KR100438633B1 (ko) 2004-07-02
AU705667B2 (en) 1999-05-27
DE69608721T2 (de) 2000-10-05
ZA961774B (en) 1996-09-17
JP3204901B2 (ja) 2001-09-04
DK0731099T3 (da) 2000-09-25
EP0731099B1 (fr) 2000-06-07
PT731099E (pt) 2000-11-30
CZ66796A3 (en) 1996-09-11
EP0731099A1 (fr) 1996-09-11
ES2147320T3 (es) 2000-09-01
MY117526A (en) 2004-07-31
EE9600030A (et) 1996-10-15
PE43597A1 (es) 1997-12-26
CN1134419A (zh) 1996-10-30
SK29796A3 (en) 1996-10-02
HRP960071A2 (en) 1997-12-31
SV1996000015A (es) 1997-02-17
JPH08253466A (ja) 1996-10-01
DE69608721D1 (de) 2000-07-13
DZ1998A1 (fr) 2002-07-20
SI0731099T1 (en) 2000-08-31
HUP9600549A3 (en) 1998-04-28

Similar Documents

Publication Publication Date Title
BG100396A (bg) Производни на n-(3-бензофуранил)карбамида,метод за получаване и използването им
US6169092B1 (en) 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
EP0685474B1 (fr) Dérivés de oxalylamino-benzofuranne et -benzothienyle
EP0779291B1 (fr) Benzofuranyl-urée substitué par un héterocycliquecarbonyle
EP0737671B1 (fr) Composés de l'acide hydroxamique aromatique, leur production et utilisation
EP0685475B1 (fr) Dérivés de aminobenzofuryle et -thienyle
SK282676B6 (sk) Benzofuránové karboxamidy a tioamidy, farmaceutický prípravok s ich obsahom a ich použitie
US5773467A (en) Benzofuran sulphonanmides
ES2204171T3 (es) Derivados de furopiridina y su utilizacion terapeutica.
US6610687B1 (en) Benzofuranylsulfonates
WO2000069841A2 (fr) Benzofuranylaminoalcools
CZ390392A3 (en) Benzofuranyl- and thiophenylmethylthio alkanecarboxylic acid derivatives, process of their preparation and use
WO2000069844A1 (fr) Derives de pyridofuranyluree et de benzofuran-3-yle a substitution oligohydroxyle convenant comme inhibiteurs des phosphodiesterases iv
GB2350112A (en) Pharmaceutically active cycloalkyl ketones